pfizer is a fabulous endorsement.sales force, best there is "mad money" back after the break. before you can achieve a higher standard of craftsmanship, you need a higher standard of craftsman. see for yourself at the lexus golden opportunity sales event. get 2.9% financing on the 2018 ls 500. experience amazing at your lexus dealer. with a $500,000 life insurance policy. how much do you think it cost him? $100 a month? $75? $50? actually, duncan got his $500,000 for under $28 a month. less than a dollar a day. his secret? selectquote. in just minutes, a selectquote agent will comparison shop nearly a dozen highly-rated life insurance companies, and give you a choice of your five best rates. duncan's wife cassie got a $750,000 policy for under $22 a month. give your family the security it needs at a price you can afford. with tripadvisor, finding your perfect hotel at the lowest price... is as easy as dates, deals, done! simply enter your destination and dates... and see all the hotels for your stay! tripadvisor searc

we talk about apple and tesla all week and pfizer was up 6% and kraft hines up 7% and coarse up 8% and a big week for apple hitting a trillion dollar market cap up 9%. we thought it would be a good time to play trade it or fade it >> i think we understand. >> if you tell us if your trading it, and fading it, aka, selling it >> and we play this gaumme a lo and in this case, fade it is the right thing. fade it doesn't mean necessarily short it, but you had this big run-up and you have insider selling here take some off the table and fade it >> look at that chart, though. for a chart that's done nothing for the last three years, the technical guy in me tell us me this chart is breaking out >> it very well could be, right? you've had this massive run up here, why wouldn't you take a little off the table if you're a technical guy, buy it off support >> i think health care has been defensive. so if the market is going to turn around and you're looking for yield and if yields don't rise as fast as we think they're going to i think they'll be in the space. i'll own pfizer forever and i'll cont

keep an eye on pfizer shares.look at the market overall now as we await some comments from president donald trump entree due to come at the top of the hour. we are getting a nice little bounce after the headlines on train -- on trade. mexico and the u.s. have come to an agreement on bilateral trade. we may have a nafta deal once again eventually. and the s&pp .8% 500 is up two thirds being led higher by advanced utilities. nasdaq is the best performer of the day up .9%. this is bloomberg. ♪ vonnie: it is 11:00 a.m. in new york, 5:00 p.m. in london, and 11:00 p.m. in hong kong. minutes into the trading session, 90 minutes into this session andto the 30 minutes left in europe. i am vonnie quinn. romaine: i am romaine bostick and this is the european close on "bloomberg markets ." here are the top stories we are covering. president trump is expected to speak about trade. we will bring that to you. u.s. and mexico have said to have reached a bilateral trade deal. u.s. stocks are reaching an all-time high. london is cl

so that's why pfizer, as mr.cahn just said, pfizer's ceo ian reed said they're getting rid of the rebates. they are running the numbers, and bring drug prices down for the industry 40%. trish: that would be wonderful for the american people. getting back to the deal, if you're paying $60 billion for something that could potentially really lose its business or ordinary profitability -- >> exactly. that is his whole price. why would you pay 60 billion for a company that is middleman that might get squeezed especially if pfizer says we're not in the rebate business anymore. express scripts manages all the nitty-gritty of getting people their products, their prescriptions. that is tough. so it's a logistics business. trish: it is worth something but maybe not -- >> insurance companies don't want to do that. it is not worth 60 billion. that is mr. icahn's point. trish: he also made a point in the letter, that the industry itself is changing so vastly and so quickly and there is the potential for so much disruption, wh

so pfizer is a biopharmaceutical company with a wide-ranging drug portfolio and we think that's a realistinction for pfizer and we think it limits its exposure and the risifto any one sp drug and as we look at the company's drug pipeline, we think it's a bit underappreciated and we expect revenum pfizer to accelerate if the drugs in the pip line are converted to sales in the next three years. >> and then there's anfanel and we're going to fiber optics and cable, and thisoes all o that, doesn't it? >> right. anfanel is a bit under the radar company and it's a supply chain for electronic manufacturers around the world and they make electronic components into automotive devices and into aircraft electronics and we only think that positions very well for the trend we'rein seein which electronics are proliferating across the economy and across the globe. >> next we go to your final pick which is 3m and also a global play. you point out the dividend and its paid the dividend, and it's raised the dividend payment for 60 consecutive years. >> s3m generally thought of as an industrial conglomer

pfizer took up to the day and put up a pfizer chart and the stock is going from basically 37 to 41.iggest move its had in a couple of weeks. your question to karen is spot on we can come say the vix is at some sort of level, and we can absolutely have that conversation and in the meantime it keeps grinding higher so to answer the original question federal express. if you liked ups at almost 16 times forward earnings, that stock is seen and given its valuation and the environment that we find ourselves in, and by the way, if the post office raises prices which the president talks about all of the time i happen to think that's a good thing for ups and federal express, as well for all those reasons i think fedex is -- >> speaking of top, nice haircut. i took it down in a major way. i mean thshgs i, this is 1981 c >> yeah, baby! >> yeah baby, is right >> it's impressive they have, i would argue have been the leadership over the last couple of months and the rails are an even better place to be investing. >> check out shares of disney in the after hours. the stock is a little volatile th

vrp, iron mountain, pfizer, royal dutch shell and ups.m i diversified >> i really like this portfolio. i love the income. i have to admit i love the income document management. real estate investment, you do not trade together i like this brookfield, a solution for companies trying to figure out what to do with the real estate. pfizer drug, oil and transport from u.p.s all good yielders, transport, oil, a drug company, retail and document that is terrific i like that and like the concept of using the stock market to bring in a little extra money. how about roy? >> caller: booyah. calling from port st. lucie, florida. >> i have been there love it. >> caller: i'd like to play am i diversified. >> sure. families let's play >> caller: my stocks are g.e., pfizer, apple, facebook and sono am i diversified >> okay. man, these guys are playing "hardball" for here. you have industrial in g.e. and upgraded we have pfizer drug company, apple, one of our favorite tex then we have two other companies, i will call sonos a tech even though it's a housin

i thought there was a pfizer warrant to spy on him. but there wasn't? >> of course there was. >> tucker: isn't that warrant for spying on someone? >> it wasn't really spying. what they were doing was authorizing -- you are trying to parse something that's not -- george papadopoulos bragged about the fact that months before anyone had ever heard of carter page in our world, about the fact that the russians had dirt on hillary clinton, he bragged on that. and it was a very alarming u.s. intelligence. >> tucker: was papadopoulos charge for espionage? >> he pled guilty to a felony. >> tucker: to espionage? oh, to lying to federal agents like martha stewart. how is that not spying? if you get a warrant to spy on someone and surveilled thatur person, maybe it's justified. you are arguing a different point. my point is to say it's not spying is of course the definition of dishonesty. >> the the trump people insistt carter page was not working the campaign as of the time that pfizer warrant was authorized. and only republican judges authorized it time and time

research and development, pfizer stepped back and had very substantial layoffs. what it has done to the local economy. people who spoke in real estate and the guy who runs the bowling alley and a gentleman who has an insurance company and he described what has happened to the housing crisis and jobs. the guy from the bowling alley said would have been with all these layouts is industry has moved offshore and we lost protection. it is changing rapidly. a couple weeks ago. a man who ran an insurance company and he says thank you, but i've got to shut down my business. the loss of these businesses have a profound effect on businesses around the united states. you might hear it in the local paper, but it is devastating to people, to their families. some are devastated and setting up high investments in china than they are hiring the phd researchers had a third of the cost. we have these germanic dislocations that have a huge impact on our economy. the final point is we have to decide is a country, do we want to have an industry like pharmaceuticals here in the united

pfizer folded like a tent. then it rov. >> not talking about the stock the company with its pricing >> absolutely. >> the stock is is still up 10% in a month >> you know what's good about those, those tweets he desensitizes the markets think of health care's growth. think of defense beyond pfizer 2019, like hca holdings. look at medical devices. congress is talking about offering tax relief to the medical devices relief boston working -- >> to red bull before f we begin. here's where we deliver. those are solidly value. just got to categorize it the hospital names, you call them growth. the valuations and price returns on those sectors don't have the same beaten down value characterist that i can the bio tech and farm ma sector has. if you talk about the rotation from tech names into health care, those names, manage d care and hospitals have performed nicely >> are we ready to talk about that or not? >> it's a little early >> we've been waiting f g fing forever. for the sector rotation that just hasn't rotated

a three or four-week pfizer drug like last couple of weeks in the last six years. something clearly is going on. i think the bull's-eye office their back i think it is now off their back >> when i look at this market and i look at the move down and the market and how it rallied and the outperformance of transport which is is probable 7% of bank which is is probably 4% of the discretionary and not necessarily xrt and individual names of the retail space that have been on fire and most importantly, earnings gave credence to the argument that those cheap valuations, and look at what happened with the airlines and the banks this to me is the nice thing about earnings and fresh data points that are giving you and rea firing and in some cases beating. >> we have coming up in the near-term and discretionary is moving well. what are you watching? >> today in discretionary,% michael kors who isboth a trading and clothing company and it bodes well for others in the space and we saw dillard's with numbers. it is interesting, we're talking to kudos, retail, transports a lot of

. >>> pfizer's experimenta study shows promise. the medication reduced the risk of death in people with a rare heart disease by 30%. concerns were raised in the competition in the space. shares of pfizer were off nearly 2% to 41.58.an ile, shares of ionis, which make competing therapirs, saw t shares jump. netflix is reportedly testing out a system in af number international markets that lites new users subscribe to the reaming platform on devices. netflix shares rose more than 1% to 3.64.58. bloomberg reports that the company willee debut t new iphones with its largest ever, with a 6 1/2 inch screen, apple has yet to announce a date for that. the stock rose a fraction. >>> vm wear is buyin cloud health technologies in an effort to expand and streamline his cloud offerings, vm wear did not disclose a price for the deal. but they're expected to pay about $500 million. shares fellct fn to 150.03. shares of thehiaker rose after investors got a chance to react to a new productun anment over the weekend. the company said it was launchin

however, tim collins on an off the chart segment said, you know what, take a hard look at pfizer the world's largest pharmaceutical company would be the kind of company i would shun but if you take a look at this chart, you can see that pfizer traced out a left shoulder as it rallied through the month of act and then started declining aggressively, okay, in november. the stock bottomed to form the head then in december caught a rally. then a pullback to create the right shoulder the key with this pattern is the neckline the line that connects the head to the two shoulders when a stock breaks out it tells a technician you're about to witness a big move pfizer's neckline was $25.80 collins predicted if it takes out that neckline it could be in for a monster run. i was confounded by this bullish reverse head and shoulders pattern. i didn't trust it one bit. i mean, come on, i'm the king of rotations. i knew it was a bad stock. collins said rotations you ought to close your eyes and buy the stock because something big was going on it was inconceivable sure enough, he was right, i was wro

. >>> and pfizer has recalled a specific flavor of children's advil. it is suspending the bubble gum flavor. pfizer said the instructions are marked in milliliters but the dosage cup is marked in teaspoons you. return it for a refund. to learn more head to our website, abc7news.com. >>> all right. on to the weather forecast as we start another week. >> all right. the air is getting cleaner, and that's good news, sandhya. . that is indeed. and we can breathe a little easier as a result, dan and kristen. i want to show you time lapse from our mount tamalpais camera as we have a very deep marine layer in place. it was rushing back in over the bay from the coast. and if you look carefully here, there was still a little bit of a sign of some smoke from the wildfire, especially in the north bay. now air quality has started to improve. and over the next two days, you're going to notice much better air quality on wednesday it's going to be good. tomorrow still moderate for parts. live doppler 7 showing you how gray it is right now. it is pretty much cloudy int

. >> reporter: mylin says it's exploring options with its manufacturing partner, pfizer, to stabilize supply. pfizer says it's experiencing delayed shipments due to process changesnd cited supply of third-party components in the manufacturing process. epipen isn't the only option on the market. there's also the click and the avicue, b it's the most dominant. >> the school prefers the epipe' because t what they have trained their staff in how to administer. >> reporte just this week fda approved the first generic competitor to the ipen. mylin introduced its own generic at t end of 2016. this is the first directly bstitutable productold by another company. that company, teva sarmaceuticals, said i applying full resources to the launch in the coming months. but that may not be soon enough to help parents like alir get ready ck to school. as hudson prepares to start first grade, his ipen is one of his most important school supplies. >> to read more about the epipen shortage, head to our website at nbr.com. >>> the new status symbol on american highways coming up. >>> are you ready for the

the revised guidance came after pfizer reported stronger than expected earnings that were led by higher of its key drugs and it plans to ramp up invtments in research and development in order to bolster the current product pipeline. shares rose 3% to 39.93. procter & gamble said that increased invtments and growing competition caused its sales to rise at a slower-than-expected pace especially in the consumer product giant's sving business. earnings overall, though, were ahead of expections and p & g said it would raise prices on a number of its products in response to higher commodity costs.e sh was procter & gamble rose nearly 1% to $8.88 today. french drugmaker sanofi topped estimates and it did see sales come up short as weakness in the diabetes division runs short. recent acquisitionsill sition that business for growth in the second half of this year. sharhe fin up 1% today to 43.36. and health insurer wellcare topped profit expectations with dsults being hely higher premiums and lower medical costs. the company i said thats seeing strength across its businesses and its result that

as it wrong that pfizer courts would like to?eminated to the american people and where is mueller? >> the hillary clinton investigation was corrupt. they liked her, hated tron. the initial russia investigation was corrupt at its core. the same guy started the russia investigation, peter strzok. i don't know why we have a special counsel. i can't explain it to people in south carolina. >> sean: pfizer courts, would you ever lie to a judge? would you delete subpoenaed emails? >> i would tell him he's on the payroll, you better consider that. the bottom line it was corrupt and we need to make sure it doesn't happen again. >> sean: but we are going after people for tax evasion and loan issues. >> the bottom line is this is just going to be a lot of noise if he did not collude with russia, and i do not believe he did. >> sean: our thoughts and prayers to sandy, megan and the entire mccann family. >> i am better off or have known him and he left his country. as a little john mccain in all of us. if we can bring that out the country wou

your dow leaders, pfizer, verizon, caterpillar and apple they're all helping to lift the dow.se are all gains of more than 1% your laggards, mcdonald's, microsoft and intel are lower. bill. >> michelle, elon musk, boy, have you read this "new york times" interview yet >> what interview? >> elon musk telling "the new york times" it's been a painful and difficult year for him and it may be getting worse. today tesla shares fall 8% heading for their worst day in nearly five months phil lebeau joins us from chicago to talk with "the new york times" interview with elon musk. >> what was most interesting is when you got a glimpse into what's going on with elon musk and his state of mental health, state of physical health and a couple of quotes stand out, especially with regards to the tweet that he sent out first of all, he says in regard to his health, it's not been great, actually. i've had friends come by who are really concerned the reason that musk did this interview because the heat he has received and tesla received over the last week and a half because of the tweet he sent o

let's check the dow 30, big pharma pfizer and merck holding gains along with travelers and the down day on wall street there is some green up there, walgreens, boots, verizon and 3 m, in the green the dow up 182 a lot better than it was this morning when it was down more than 300 points and a comeback, kind of. up next trade wars blamed for the days sell-off but could a trade war turn it all around? the mexican trade minister is in the nations capitol. edward lawrence will have the latest on finding a deal for a new nafta, that's next on countdown. >> on the next kennedy the president's war of words with former white house aid omarosa continues, how much nasty will it get? join me right here. .s. it's america's most popular street name. but allstate agents know that's where the similarity stops. if you're on park street in reno, nevada, the high winds of the washoe zephyr could damage your siding. and that's very different than living on park ave in sheboygan, wisconsin, where ice dams could cause water damage. but no matter what park you live on, one of 10,000 local allstate agents kno

pfizer reversed its price increases. merck announced that it's going to be decreasing prices. we've had several other companies who had told state regulators that they were going to increase prices, and they have now walked back and said they will not follow through on those increases. and we've seen over a dozen companies say that they will have no further price increases for the rest of the year. we'll be coming out with a report on the hundred days' progress that we've made so far next week, and that will have even more information for you about the historic changes we're already experiencing in the drug pricing market. we've done some transformative things under the president's leadership already. for the first time in history, the president is introducing a regime to important drugs from other developed countries that do not violate intellectual property rights in the united states here. so these are products that are not under patent protection, but where the company -- the single company -- holds that drug in the u.s. and has increased price. we're going to let competit

increases are stopping like with pfizer. we are stopping hospitals from overcharging low income seniors for the same prescription drugs. we passed a veterans choice, our veterans are the greatest. i said that is a bad situation with the vets, they are really being treated badly. these are really our greatest people as far as i'm concerned. the vets would wait on line to see a doctor, six days, nine days, 21 days. sometimes 34 days. some of them would have a minor condition by the time they saw the doctor, they were terminally ill. i said we are not going to let that happen. i came up with an idea that i felt was brilliant, i said you know what, we have all these doctors, some of them are really good, talented doctors. they are in the neighborhoods where these vets are trying to get taken care of. we are going to let the vets go see the doctors and we are going to pay their bills. [cheers and applause] i said, this is so brilliant. and then i presented it to congress and the congressman said yes, sir, we would try to do this

treatment of the cancer patient but a validation experiment compared with the regular blood tests that pfizerwas doing regularly. but employees were still all that is terminal cancer patient were being put through the fingerstick withdrawal several times a day for a technology that absolutely did not work. then in the middle of that study she pivoted away from the microfluidic platform that was essentially a glued and see a robot from a company in new jersey be. >> that is made to dispense glue at the end of the robotic arm has agreed to be the motion and forward and back and he reprogrammed the robotic arm mimic what a scientist would do at the bench testing blood. when that hit it to that machine happened some employees felt let down because it was a huge step down from the microfluidic so they would rightly refer to the machine as the bought one -- glue robot. [laughter] she had a well-known industrial designer design a me black and white case to hide it inside and christened it the edison after thomas edison and this happens with this visit essentially a completely different machine and m

and we are learning about the pfizer court which republican supported at one time, we learned about the police system, we learned about corruption in the doj and the fbi. what i cannot understand is the party that has always rallied against that now all of a sudden loves the fbi and loves the doj. >> let me back up for one second, and, that was the least sloppy thing that you could do is recuse yourself. the swamp urethane would have been right in there. to me, i don't see that as a swamp thing. this is the one area that i do have concerns with, the rhetoric surrounding the justice system. yes, there are bad apples, but there are bad apples in any sense any institution. we cannot erode and create panic amongst the american people. >> i think -- of the department of justice looks pretty panic were they. the system as a whole should work, and i'm with you, i think jeff sessions probably did the right thing. i'm kind of tired of of talking about it and i don't know why they are always railing on it, but regardless, the justice department is really political and they are weaponizing a lot o

the dossier obviously making it to the pfizer court. and one was to be concrete evidence, and that was obviously over the fusion gps. it will be a closed-door hearing, and this won't be 5 minutes of back and forth, people trying to get a video clip for the nightly news. this will be something that we are able to dial down and get to the bottom line. we want answers and we believe that specifically, knowing now that he financially benefited and how and why, let's follow that people paper trail. >> there are so many motivations that people have whatever the issue is, so that will be some of the questioning here. as far as fusion gps is concerned, we also know that the democratic party and the clinton campaign was funding some of this research done by christopher steele, a full accounting wasn't presented in full and complete to the pfizer court. when you boil all of that down, the answers that he gives, will that clear up any of the explanation for how all of the information and that before the court? >> that's what i'm talking about. not

. >> that's where i've been adding most to, and i have gilead and celgene, along with merck and pfizer some of those names the problem with that in addition to a football player, andy think a lot of the stuff that's been somewhat cheap has been cheap and stayed cheap. i think the dilemma here, and the consumer names and consumers outperformed qqqs by about a thousand basis points in the last 12 calendar months and you really outperformed there and the cheap stuff like banks and you know, stuff that frankly, i think should outperform, too, pete and the question for professors, and i know dan's got a view of this since the markets hit the turbulent moment and they haven't shaken out the rust >> cheap is one of the economically sensitive and cyclical groups and you're talking about the banks and the xlf did not remain a new high. >> the tcm is down from its 52-week high it's all horrible. they act atrociously and let's get to emerging market we spnt a whole show yesterday talking about u.s. political stuff and we're all in agreement that that's not where the big threats are to the market

pfizer reversed its pricing announced that it will decrease prices. several other companies told regulators they were going to increase prices and they have now walked that back. we have seen a dozen companies say they will have no further price increases for the rest of the year. we will have a report on the progress we have made so far and we will have more information on the historic changes we are seeing in the drug pricing market. we have done transformative things with the president's leadership already. the president is introducing a regime to import drugs from other developed countries that do not violate intellectual property rights. these products are not under patent protection, but where a single company holds that drug in the u.s. and has increased prices. we will let competition to come in to allow patient access for the first time in history. for the first time in history, president trump is bringing negotiation and discounts to our medicare partners. that is the drug program were doctors administer the drugs. for all of its history, we

pfizer, and others, and have brought them back down to where they were. we're working very hard.ar is with czar -- a me. we went to a hospital, so beautiful. and i are working very hard on eliminating the middleman, and we are going to bring restriction -- because it is already happening -- friendly, pfizer and all could not have done what they did for weeks ago, and we are bringing drug prices down, prescription drug prices. we reformed -- it is such an important -- we reform the medicare drug discount program to stop hospitals from overcharging low-income zero years, saving seniors hundreds of millions of dollars this year alone. why didn't they do this before? we will always protect our seniors. we will take care of our seniors better than they have in ever taken care of. we've also appointed and confirmed a record number -- highest number -- of judges who will interpret our constitution has written -- as written. as written, as opposed to judges that just make it up as they go along. we passed a landmark v.a. accountability law, where we can actually fire people if they are b

the pfizer report, the phony -- >> paul manafort signed the pfizer report. will you fire him, will you fire sessions? >> i wanted to stay uninvolved, but when everyone sees what's going on in the justice department -- i always put justice now in quotes -- it's a very sad day. jeff sessions recused himself, which he shouldn't have done. what kind of man is this? and by the way, he was on the campaign. he knows there was no collusion. what's come out of manafort? no collusion. what's come out of michael cohen. no collusion. >> if the democrats take back power, do you believe they'll try to impeach you? >> i guess it's something like high crimes and all. i don't know how you can impeach somebody who has done a great job. i tell you what, if i ever got impeached, i think the market would crash. i think everybody would be very poor. i give myself an a-plus. i don't think any president has ever done what i've done in the short term. >> is the press the enemy? >> no, but the fake news is. and the fake news is a big chunk, okay? somebody said, what's the chunk? i sa

. >>> well, look at pfizer. not so great. pfizer is bringing up the rear in the dow 30 after results of its heart drug failed to impress analysts and investors. the stock is down nearly a buck. >>> saying good-bye to a maverick. we are in phoenix, arizona with all the details on the events this week to honor the passing of knosenator john mccain. pah! that will never work. no, no, no, nah. a bulb of light?!? aha ha ha! a flying machine? impossible! a personal' computer?! ha! smart neighborhoods running on a microgrid. a stadium powered with solar. a hospital that doesn't lose power. amazing. i like it. never gonna happen. [music playing] (ceo) haven't been playing golf this year, i am sorry about that. (vo) progress is in the pursuit. audi will cover your first month's lease payment on select models during summer of audi sales event. the doctor just for a shot. with neulasta onpro patients get their day back... to be with family, or just to sleep in. strong chemo can put you at risk of serious infection. in a key study neulas

otherwise, pfizer and all could not have done what they did four ago.ices down, prescription drug prices. we reformed -- it is such an important -- we reformed the medicare drug discount program to stop hospitals from overcharging low-income zero -- seniors. hundreds ofrs millions of dollars this year alone. i asked, why didn't they do this before? we will always protect our seniors. we will take care of our seniors better than they have in ever -- they've ever been taken care of. we've also appointed and confirmed a record number -- highest number -- of judges who will interpret our constitution as written. as written, as opposed to judges that just make it up as they go along. we passed a landmark v.a. accountability law, where we can actually fire people if they are bad to our great veterans. and as i said, we also passed a veterans choice, something they have been trying to get for 45 years, veterans choice. and i'm so proud of that one, in the senate came through and the house came through, and it was not easy, but we now have a plan -- you know, t

especially around drug pricing on the first topic, that stock up about 27% in august on data from pfizer that was competitive. analysts seeing it was good data, but also to compete there. they're seeing quite a bit of performance. in terms of the fda, considered a friendly agency. and third, drug price, we haven't heard a lot of new news around that. we've seen some action, but nothing anybody seems to think is going to hurt profitability while driven by smaller caps in this space, some bigger companies have posted sizable gains. if you check on regeneron and celgene, up between 4 and 11%. however, not all big companies are participating. gilead is up about 3% this week, it has given back almost that much for this month, guys, so not everybody participating. it>> it's a good set up. celgene up 5%. >> i own it. >> that's 5% a month >>all athey were so oversold. these stocks cratered over the last look at allergan, most over the last year, that they were ripe to start to go upward once the bad news was priced in the other thing and meg, you talked about this, is that the political rhetoric

of them about investigative bias, the angry democrats at the president so often tweets about, the pfizer court and how the dossier ended up before the fisa court. they set the timeline, it's tomorrow, for a mueller to essentially come forward and wrapped the probe. any chance of that happening? should we expect a big announcement today merely because the president's lawyer has suggested a given date? >> james: i still don't think we are there yet, but what once seemed unreasonable to people eventually will become reasonable because he does have the authority. the president runs the justice department and if he says it's time to investigate other things, he does have that authority. i think now people may eventually start saying, you've looked at it enough. the one i want to take things back to where the granddaughter of aretha franklin is speaking. let's listen. >> every time i learned something new about my grandma, i see that i have so much of her in me and it makes me smile. i'm so proud to have someone like her in my life to pave the way for me. i love you grandma, and i will make yo

pfizer is a y°93 especially our hearts.r work. as soon as i come into london, getting off that train, i feel like there is this cloud of smoke and i insta ntly there is this cloud of smoke and i instantly get breathless. when i'm trying to walk, i notice if it is a busy road, i'm subconsciously already placing my hand by my nose just to avoid breeding anything in. researchers examined information from thousands of people and found that there was a link between those living next to busy roads and changes to the ventricles of the heart, changes that can lead to heart, changes that can lead to heart failure. there are things you can do such as walking on a side road rather than a main road. walking and cycling where possible. there are steps that you can take, but ultimately people shouldn't be having to live in areas with high pollution, so we need a reduction in the levels across the country. the mayor has made cleaning up london's air his priority. he has tried to clamp down on polluting vehicles with the introduction of an

you look at what's happening with pfizer over the last week, week and a half since president trump put the bull's-eye on his back since it's castigated i think it comes in the form of health care >> so i think apple is both, right? we talked about that netflix is definitely growth and i think you have to have a fair share of growth and the damage has been done to the growth side of the equation. i do think you see some money coming back in there because i think when people start to look at value, karen said how do you judge value, and i think people are perplexed with that saying am i going to get any type of appreciation in stock price, in capital return or anything what is value and what's growth? they'll come back to the name that has run the bull market for the last two years >> i was literally thinking. >> you were going to say castigated >> no. that's a big word. >> i never worked on the farm, but when i looked at health care thank you. the health care side of it, though, you do have a lot of names out there, whether it's pfizer or merck and even biotech. >> health care has been

security here samuelson, director of the national security agency general called tony national security pfizer john bolton to make comments and questions on the . as you know we address during the election numerous times in rhetoric the purpose of today's briefing is about what we are doing now to protect the integrity of our elections and we ask that you stay on topic. in order to this run smoothly we ask you direct your attention and questions to ask for bolton and make comments. thank you very much sarah and what we like to address today is election security in the 2018 election and in the future. president has made it very clear i think his priority is. we've had obviously a number of inquiries from congress on this including a letter to me last couple days five senators by senator schumer and for others. i have responded to that letter today and we make copies to you and it's part of a framework for the briefing that the four operating the agency give you here today. they are the ones who are living and operationalizing . there are other agencies involved of these are four primary one and

pfizer manufacturers the drug for mylan. >> process changes >> pfizer got a warning letter from the fdathat plant, it said it did not impact things at the time, and they say there's supplier issues. >>how profitable is this generic? i assume they look at mylan price, knock it down by 20% and say here we are. >> or even more. when you asked me yesterday, i said maybe more. >> how far down do you think >> it depends. there's already the mylan authorized generic in the market >> what are the margins on that. >> on the branded one it was like a 50% profit margin i don't know what the authorized generic margin is. and we're not sure what the teva price will come in at. >> prices have come down significantly. that's the story they were doing last night >> that's the good news. >> the authorized generic is half the price people are finding they can get the branded version but the insurance only covers the authorized generic so they have to pay 300 bucks for each pack of two >> meg, thank you very much. >>> coming up, currency check. we'll talk about this morning's move in the dollar, and a wil

trying to be with us and explain what's happening there behind you there could be an assault and pfizer. the u.s. has found a new culprit when it comes to election meddling china mainstream media those still obsessed with russia's alleged involvement in american votes and now it's raised the alarm over the upcoming midterms to wrapping all this up caleb maupin. as america prepares for the mid-term november elections the mainstream media is beating that same dead horse from twenty sixteen if there is a problem you know who we can blame us and hackers ahead of them in ten i was arrogant and security of our next election the russians are targeting members of congress the us midterm elections are just around the corner and russia's attack continues to haunt the united states russian election interference in the twenty thousand midterms the russians have not reduced their hacking but it looks like russia is not the only country capable of assembling an army of keyboard crunchers to maniacally dismantled democracy trump says that another global adversary of the united states is getting in on

pfizer reversed its price increases. merck will be decreasing prices.e have had several other companies who told regulators they were going to increase prices and have now walked back and said they will not follow through on those increases. we have seen over a dozen companies say they will have no further price increases for the rest of the year. we will be coming out with a report on the hundred day progress we have made so far next week, and that will have even more information for you about the historic changes we are already experiencing in the drug pricing market. we have done some transformative things under the president's leadership already. for the first time in history, the president is introducing a regime to import drugs from other developed countries that do not violate intellectual property rights in the united states. these are products that are not under patent protection but where the company, the single company, holds that drug in the u.s. and has increased price. we will let competition come in to ensure patient access and competitio

to remind everyone that this entire of -- investigation was started by a conspiracy to defraud the pfizer court. -- fisa court. we are seeing a communist coup under color of law. thank you. guest: i do think that the special counsel with this roving mandate to investigate, see if you can find anything, anyone around trump. this is soviet justice. have a commission. it was started because james comey was out there while he insinuating the president was under investigation. as a quote in the book, when james comey was fired, all of the news media, we get echoes of watergate all the time with republicans but especially trump . iswas all about, trump under investigation and he fires the man investigating him. months later, james comey finally admitted trump was not under investigation and the entire basis for the special counsel, the president is under investigation, no, not only was he not under investigation, when we found out there were spies on me trump campaign, the fbi said we were not spying on you, we were protecting you. now we have it on the authority of investigators, known only tr

son into an emperor fit to rule the world above all however seneca would become nero's closest and pfizer. by the year fifty agrippina managed to persuade her husband emperor claudius to adopt mira. agra pino was conferred with the honorary title of agosta a title no imperial wife had acquired so young. claudius had been in power for a decade he loved mushrooms says the tony is noted and two young girls. his wife and niece agrah pina was twenty six years his junior and she had. plans ancient historians describe the emperor as ignorant weak and mean. modern scholars view him as an excellent administrator and of the thoughtful ruler. this is ours who tony has recorded the day of october thirteenth fifty four. the imperial family is gathered around the table. mushrooms are on the menu claudius whose favorite dish. nero the devoted son is that his mother agribusiness. courters his biological son britannicus is also there. claudius dotes on the board narrows biggest rival in the line of imperial succession. so tony skews a detailed account of the plot to murder claudius who had sealed his fate

it is world noting as -- worth noting as for note inhighs disney hit a multiyear high as did pfizer anderck, and apple hit all-time high today, it pulled back but they are breaking out. back to you. liz: all right. thank you nicole, we'll stay on the story about musk, confirms his intention to go private via tweet. is this a brave new world for all investors that ceos tweet out information that rocks the markets. >> and also, a video now going viral ivy league millennials trying to explain what their understanding of the first amendment is. >> freedom yo under first amendment. >> freedom of -- um. >> and um? >> what are professors teach their kids, also tonight, a new report democrat using the fake news crackdown to try to grab more government control of the internet, judge andr and drew napolitano says watch out. >> and bernie sanders stumping for a michigan gubernatorial candidate, looking to implement a bunch of socialist policies. details coming up, stay there. this isn't just any moving day. this is moving day with the best in-home wifi experience and millions of wifi hotspots to h

and pfizer recalling some of its children's advil liquid medicine.t coming up. and it's thanksgiving in august. starbucks releasing its famous pumpkin spice last a todays just one day after dunkin' donuts started selling theirs. and what a catch. a cubs' fan catching a fly ball in his beer cup and how he celebrated. that's a big get down right there. go, cubs. here to break it down with me, lindsay bell, chief market strategist michael block and brewer group ceo, former nfl star jack brewer. good to see you this morning. >> great to be back. dagen: good to see you. we will get into everything. a lot of federal reserve information but right now i'm going to talk about the trade deal. to our top story this hour. a done deal, president trump striking a new deal with mexico to revise key pieces of the original nafta agreement. the pact, which the president is proposing to call the u.s./mexico trade deal, will focus on heightens automobile production in the united states and increased protection for holders of intellectual property. the president says the